Report Detail

Medical Devices & Consumables COVID-19 Impact on Global HIV Point-of-care Testing Market Insights, Forecast to 2026

  • RnM4067484
  • |
  • 18 June, 2020
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

HIV Point-of-care Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HIV Point-of-care Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the HIV Point-of-care Testing market is segmented into
Testing Equipment
Testing Reagent

Segment by Application, the HIV Point-of-care Testing market is segmented into
Hospitals
Clinics
Home Care Setting

Regional and Country-level Analysis
The HIV Point-of-care Testing market is analysed and market size information is provided by regions (countries).
The key regions covered in the HIV Point-of-care Testing market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and HIV Point-of-care Testing Market Share Analysis

HIV Point-of-care Testing market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of HIV Point-of-care Testing by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in HIV Point-of-care Testing business, the date to enter into the HIV Point-of-care Testing market, HIV Point-of-care Testing product introduction, recent developments, etc.
The major vendors covered:
Abbott
BD
Biomerieux
Adaltis
Roche


1 Study Coverage

  • 1.1 HIV Point-of-care Testing Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top HIV Point-of-care Testing Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global HIV Point-of-care Testing Market Size Growth Rate by Type
    • 1.4.2 Testing Equipment
    • 1.4.3 Testing Reagent
  • 1.5 Market by Application
    • 1.5.1 Global HIV Point-of-care Testing Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Home Care Setting
  • 1.6 Coronavirus Disease 2019 (Covid-19): HIV Point-of-care Testing Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the HIV Point-of-care Testing Industry
      • 1.6.1.1 HIV Point-of-care Testing Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and HIV Point-of-care Testing Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for HIV Point-of-care Testing Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global HIV Point-of-care Testing Market Size Estimates and Forecasts
    • 2.1.1 Global HIV Point-of-care Testing Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global HIV Point-of-care Testing Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global HIV Point-of-care Testing Production Estimates and Forecasts 2015-2026
  • 2.2 Global HIV Point-of-care Testing Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global HIV Point-of-care Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global HIV Point-of-care Testing Manufacturers Geographical Distribution
  • 2.4 Key Trends for HIV Point-of-care Testing Markets & Products
  • 2.5 Primary Interviews with Key HIV Point-of-care Testing Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top HIV Point-of-care Testing Manufacturers by Production Capacity
    • 3.1.1 Global Top HIV Point-of-care Testing Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top HIV Point-of-care Testing Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top HIV Point-of-care Testing Manufacturers Market Share by Production
  • 3.2 Global Top HIV Point-of-care Testing Manufacturers by Revenue
    • 3.2.1 Global Top HIV Point-of-care Testing Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top HIV Point-of-care Testing Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by HIV Point-of-care Testing Revenue in 2019
  • 3.3 Global HIV Point-of-care Testing Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 HIV Point-of-care Testing Production by Regions

  • 4.1 Global HIV Point-of-care Testing Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top HIV Point-of-care Testing Regions by Production (2015-2020)
    • 4.1.2 Global Top HIV Point-of-care Testing Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America HIV Point-of-care Testing Production (2015-2020)
    • 4.2.2 North America HIV Point-of-care Testing Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America HIV Point-of-care Testing Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe HIV Point-of-care Testing Production (2015-2020)
    • 4.3.2 Europe HIV Point-of-care Testing Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe HIV Point-of-care Testing Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China HIV Point-of-care Testing Production (2015-2020)
    • 4.4.2 China HIV Point-of-care Testing Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China HIV Point-of-care Testing Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan HIV Point-of-care Testing Production (2015-2020)
    • 4.5.2 Japan HIV Point-of-care Testing Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan HIV Point-of-care Testing Import & Export (2015-2020)

5 HIV Point-of-care Testing Consumption by Region

  • 5.1 Global Top HIV Point-of-care Testing Regions by Consumption
    • 5.1.1 Global Top HIV Point-of-care Testing Regions by Consumption (2015-2020)
    • 5.1.2 Global Top HIV Point-of-care Testing Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America HIV Point-of-care Testing Consumption by Application
    • 5.2.2 North America HIV Point-of-care Testing Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe HIV Point-of-care Testing Consumption by Application
    • 5.3.2 Europe HIV Point-of-care Testing Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific HIV Point-of-care Testing Consumption by Application
    • 5.4.2 Asia Pacific HIV Point-of-care Testing Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America HIV Point-of-care Testing Consumption by Application
    • 5.5.2 Central & South America HIV Point-of-care Testing Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa HIV Point-of-care Testing Consumption by Application
    • 5.6.2 Middle East and Africa HIV Point-of-care Testing Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global HIV Point-of-care Testing Market Size by Type (2015-2020)
    • 6.1.1 Global HIV Point-of-care Testing Production by Type (2015-2020)
    • 6.1.2 Global HIV Point-of-care Testing Revenue by Type (2015-2020)
    • 6.1.3 HIV Point-of-care Testing Price by Type (2015-2020)
  • 6.2 Global HIV Point-of-care Testing Market Forecast by Type (2021-2026)
    • 6.2.1 Global HIV Point-of-care Testing Production Forecast by Type (2021-2026)
    • 6.2.2 Global HIV Point-of-care Testing Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global HIV Point-of-care Testing Price Forecast by Type (2021-2026)
  • 6.3 Global HIV Point-of-care Testing Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global HIV Point-of-care Testing Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global HIV Point-of-care Testing Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Abbott
    • 8.1.1 Abbott Corporation Information
    • 8.1.2 Abbott Overview and Its Total Revenue
    • 8.1.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Abbott Product Description
    • 8.1.5 Abbott Recent Development
  • 8.2 BD
    • 8.2.1 BD Corporation Information
    • 8.2.2 BD Overview and Its Total Revenue
    • 8.2.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 BD Product Description
    • 8.2.5 BD Recent Development
  • 8.3 Biomerieux
    • 8.3.1 Biomerieux Corporation Information
    • 8.3.2 Biomerieux Overview and Its Total Revenue
    • 8.3.3 Biomerieux Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Biomerieux Product Description
    • 8.3.5 Biomerieux Recent Development
  • 8.4 Adaltis
    • 8.4.1 Adaltis Corporation Information
    • 8.4.2 Adaltis Overview and Its Total Revenue
    • 8.4.3 Adaltis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Adaltis Product Description
    • 8.4.5 Adaltis Recent Development
  • 8.5 Roche
    • 8.5.1 Roche Corporation Information
    • 8.5.2 Roche Overview and Its Total Revenue
    • 8.5.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Roche Product Description
    • 8.5.5 Roche Recent Development

9 Production Forecasts by Regions

  • 9.1 Global Top HIV Point-of-care Testing Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top HIV Point-of-care Testing Regions Forecast by Production (2021-2026)
  • 9.3 Key HIV Point-of-care Testing Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 HIV Point-of-care Testing Consumption Forecast by Region

  • 10.1 Global HIV Point-of-care Testing Consumption Forecast by Region (2021-2026)
  • 10.2 North America HIV Point-of-care Testing Consumption Forecast by Region (2021-2026)
  • 10.3 Europe HIV Point-of-care Testing Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific HIV Point-of-care Testing Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America HIV Point-of-care Testing Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa HIV Point-of-care Testing Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 HIV Point-of-care Testing Sales Channels
    • 11.2.2 HIV Point-of-care Testing Distributors
  • 11.3 HIV Point-of-care Testing Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Market Opportunities and Drivers
  • 12.2 Market Challenges
  • 12.3 Market Risks/Restraints
  • 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global HIV Point-of-care Testing Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global HIV Point-of-care Testing. Industry analysis & Market Report on COVID-19 Impact on Global HIV Point-of-care Testing is a syndicated market report, published as COVID-19 Impact on Global HIV Point-of-care Testing Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global HIV Point-of-care Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,920.00
    5,880.00
    7,840.00
    4,576.60
    6,864.90
    9,153.20
    770,917.00
    1,156,375.50
    1,541,834.00
    408,611.00
    612,916.50
    817,222.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report